RecruitingPhase 3NCT06915480

Reducing Missed Appointments

Reducing Appointment NoShow Through Targeted Pre-appointment Messaging


Sponsor

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Enrollment

5,000 participants

Start Date

Dec 29, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

There are four goals of this project: (1) To examine the impact of different appointment reminder messages on appointment attendance; (2) to determine the added benefit of a patient navigator reaching out in advance of appointments to families at elevated risk of missing their appointment, and determine the most common barriers families face in appointment attendance; (3) to evaluate which patients are at highest risk of missing their appointment, and to determine the effectiveness of the intervention trial across different patient risk levels; and (4) to examine if the missing appointment interventions increase the socioeconomic diversity patients.


Eligibility

Min Age: 1 MonthMax Age: 24 Years

Inclusion Criteria2

  • All patients who are scheduled to be seen within the center for autism or the center for neuropsychological and psychological assessment for evaluation appointments will be automatically enrolled in the reminder message portion of the intervention trial.
  • Patients who are at elevated risk within the center for neuropsychological and psychological assessment are automatically enrolled in the patient navigator portion of the intervention trial.

Exclusion Criteria2

  • None for the messaging portion of the study
  • For patient navigation, patients \>18 years of age will be excluded.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALReminder message and patient navigation

This study will evaluate the combination of pre-appointment messages and patient navigation services.


Locations(1)

Kennedy Krieger Institute

Baltimore, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06915480


Related Trials